Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

http://pediatrics.aappublications.org/cgi/content/abstract/111/6/1333

Pediatrics www.pedjobs.org
Home Help [Feedback] [For Subscribers] [Browse & Search]


Full Text of this Article
Reprint (PDF) Version of this Article
Email this article to a friend
P3Rs: Submit a response to this article
Similar articles found in:
Pediatrics Online
PubMed
PubMed Citation
Search PubMed for articles by:
Yasuda, A. || Morishima, T.
Alert me when:
new articles cite this article
 
Download to Citation Manager
Collections under which this article appears:
Infectious Disease & Immunity
 


PEDIATRICS Vol. 111 No. 6 June 2003, pp. 1333-1336

 

Evaluation of Cytomegalovirus Infections Transmitted via Breast Milk in Preterm Infants With a Real-Time Polymerase Chain Reaction Assay

Ayako Yasuda, MD*, Hiroshi Kimura, MD, PhD*, Masahiro Hayakawa, MD, PhD{ddagger}, Makoto Ohshiro, MD§, Yuichi Kato, MD§, Onrai Matsuura, MD, Chizuko Suzuki, MD, PhD and Tsuneo Morishima, MD, PhD||

 

* Department of Pediatrics, Nagoya University Graduate School of Medicine
{ddagger} Maternity and Perinatal Care Center, Nagoya University Hospital
§ Department of Pediatric Cardiology and Neonatology, Ogaki Municipal Hospital
Department of Neonatology, Nagoya First Red Cross Hospital
|| Department of Nursing, Nagoya University School of Health Science, Nagoya, Japan

Objective. Preterm infants are at greater risk of symptomatic cytomegalovirus (CMV) infection than term infants. Breast milk is the main source of perinatal CMV infections. This study evaluated the kinetics of CMV load in breast milk and the rate of postnatal CMV transmission via breast milk from mothers to their preterm infants.

Methods. This was a prospective study of 30 mothers and their 43 preterm infants. The infants either had a gestational age of <34 weeks or weighed <2000 g at birth. Breast milk, serum, and urine samples were collected every 2 weeks until discharge, and screened for CMV infection using a real-time PCR assay. Most of the breast milk had been preserved at -20°C before feeding to the preterm infants.

Results. Twenty-four mothers (24 of 30, 80%), who had 34 preterm infants, were CMV immunoglobulin G positive. Twenty-one (87.5%) of the 24 seropositive mothers, who had 30 preterm infants, had detectable CMV deoxyribonucleic acid (DNA) in breast milk during the study period. Most breast milk became positive for CMV DNA 2 weeks after delivery. Viral DNA copy numbers increased until they peaked at 4 to 6 weeks. Afterward, the CMV DNA copy numbers decreased. Of the 30 infants who were fed CMV DNA-positive breast milk, CMV infection was confirmed in 3 infants. However, they had no clinical symptoms of CMV infection.

Conclusions. Despite the high rate of CMV DNA in breast milk, symptomatic infections in the preterm infants did not occur. These results might be associated with the method of breast milk preservation and the population we studied. CMV infections transmitted via breast milk feeding did not have much impact on preterm infants in our institutes.

 

Key Words: cytomegalovirus • breast milk • real-time PCR assay • preterm infants

 

Abbreviations: CMV, cytomegalovirus • PCR, polymerase chain reaction • DNA, deoxyribonucleic acid • Ig, immunoglobulin • IE, immediate early • CT, threshold cycle

 


Received for publication Aug 14, 2002; accepted Dec 12, 2002.

 

[For Subscribers]
Copyright © 2003 by the American Academy of Pediatrics. [Disclaimer]

 

 

 

Return to Vaccination News Home Page

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.